Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced the risk for hospitalization for any cause in patients with chronic kidney disease (CKD) with and without type 2 diabetes. The findings suggest that ...
Dec 6, 2022
0
5
A new study led by UCL researchers has identified patterns in how common health conditions occur together in the same individuals, using data from 4 million patients in England.
Dec 2, 2022
0
1532
Medication that helps reduce a person's risk of developing cardiovascular and kidney disease is a cost-effective option to treat Australia's entire population of people with type 2 diabetes, a new study has found.
Dec 1, 2022
0
45
Just as bricks are key components in constructing a building, molecules known as amino acids are essential components in constructing proteins in the body. Recently, researchers in Japan investigated the role of a particular ...
Nov 28, 2022
0
6
Findings from a new study reveal that some unexpected conditions are leading to more hospitalizations in people living with type 2 diabetes compared to the general population.
Nov 23, 2022
0
28
People who grew up in deprived socioeconomic conditions, or who were overweight in childhood, are more likely to have poorer kidney function in their 30s and 40s and are more at risk of developing chronic kidney disease as ...
Nov 22, 2022
0
6
Chronic alcohol misuse including Alcohol Use Disorder (AUD), is an overlooked risk factor for severe or fatal COVID-19, according to a review of medical and scientific studies. The review, in Alcoholism: Clinical and Experimental ...
Nov 17, 2022
0
13
Context is known to influence many spheres. And now, researchers from Japan have found that a patients' health context—that is, the other conditions a patient has—can determine whether a specific gene mutation is helpful ...
Nov 17, 2022
0
37
A team of researchers at AstraZeneca, working with colleagues from the University of Mexico and the University of Oxford, has found that a protein tied to the MAP3K15 gene variant may represent a potential target for managing ...
Cisplatin is a chemotherapy indicated to fight tumors in many types of cancer. However, it does have major side effects—especially kidney toxicity, that can lead to acute kidney failure.
Nov 15, 2022
0
6
